期刊文献+

Is myopia a protective factor against central serous chorioretinopathy? 被引量:3

Is myopia a protective factor against central serous chorioretinopathy?
下载PDF
导出
摘要 AIM: To evaluate if any association exists between central serous chorioretinopathy (CSCR) and the refractive status of the eye. METHODS: This retrospective, institutional, case control study included 499 patients, wherein 262 patients diagnosed as acute CSCR, were compared with an age and gender matched control group of 237 patients. All patients were evaluated with a detailed systemic and ocular history, objective and subjective refractions for both eyes and complete ocular examination by a retina specialist, at all visits. Optical coherence tomography confirmed the diagnosis of CSCR. ~ RESULTS: The mean age was found to be 40.7y in the study group (Group 1) compared to 38 10y in the control group (Group 2). Most common refractive status in the study group, was emmetropia seen in 191 patients (72.9%), followed by hypermetropia seen in 47 patients (17.9%) and astigmatism seen in 21 patients (8.0%). Only 3 subjects (1.1%) had myopia, which was less than or equal to 1.0 D, compared to 70 subjects (29.5%) in the control group, suggesting a statistically significant lower incidence of CSCR among the myopic patients (P〈 0.0001). With respect to the systemic factors, 26 (9.9%) patients were using systemic steroids in the study group (Group 1) compared to none in the control group (Group 2) suggesting a statistically significant association of CSCR with systemic steroid use (P〈0.05). No other significant systemic risk factors were noted. CONCLUSION: Though CSCR is a multifactorial disease, myopia serves as a protective factor for CSCR. Thus, myopic eyes are less likely to develop CSCR. Since both retinal pigment epithelium (RPE) and choriocapillaris are postulated in the pathogenesis of CSCR, chorio-retinal thinning and atrophy seen in myopic eyes are less likely to cause CSCR. AIM: To evaluate if any association exists between central serous chorioretinopathy (CSCR) and the refractive status of the eye. METHODS: This retrospective, institutional, case control study included 499 patients, wherein 262 patients diagnosed as acute CSCR, were compared with an age and gender matched control group of 237 patients. All patients were evaluated with a detailed systemic and ocular history, objective and subjective refractions for both eyes and complete ocular examination by a retina specialist, at all visits. Optical coherence tomography confirmed the diagnosis of CSCR. ~ RESULTS: The mean age was found to be 40.7y in the study group (Group 1) compared to 38 10y in the control group (Group 2). Most common refractive status in the study group, was emmetropia seen in 191 patients (72.9%), followed by hypermetropia seen in 47 patients (17.9%) and astigmatism seen in 21 patients (8.0%). Only 3 subjects (1.1%) had myopia, which was less than or equal to 1.0 D, compared to 70 subjects (29.5%) in the control group, suggesting a statistically significant lower incidence of CSCR among the myopic patients (P〈 0.0001). With respect to the systemic factors, 26 (9.9%) patients were using systemic steroids in the study group (Group 1) compared to none in the control group (Group 2) suggesting a statistically significant association of CSCR with systemic steroid use (P〈0.05). No other significant systemic risk factors were noted. CONCLUSION: Though CSCR is a multifactorial disease, myopia serves as a protective factor for CSCR. Thus, myopic eyes are less likely to develop CSCR. Since both retinal pigment epithelium (RPE) and choriocapillaris are postulated in the pathogenesis of CSCR, chorio-retinal thinning and atrophy seen in myopic eyes are less likely to cause CSCR.
出处 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2016年第2期266-270,共5页 国际眼科杂志(英文版)
关键词 central serous chorioretinopathy refractivestatus MYOPIA central serous chorioretinopathy refractivestatus myopia
  • 相关文献

参考文献24

  • 1Wang M, Munch IC, Hasler PW, Prunte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol 2008;86(2):126-145.
  • 2Liew G,?Quin G,?Gillies M,?Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Experiment Ophthalmol 2013;41(2):201-214.
  • 3Gemenetzi M, Salvo GD, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond) 2010;24(12):1743-1756.
  • 4Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S; Central Serous Chorioretinopathy Case- Control Study Group.Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004;111(2):244-249.
  • 5Yannuzi LA, Gitter KA, Schatz H. Central serous chorioretinopathy In : Yannuzi LA, Gitter KA, Schatz H eds. The macula: a comprehensive text and atlas, Baltimore MD: Williams and Wilkins 1979:145-165.
  • 6Jain IS, Luthra CL, Das T. Beneficial effect of myopia on diabetic retinopathy. Indian J Ophthalmol 1965;13(3):88-94.
  • 7Lim LS, Lamoureux E, Saw SM, Tay WT, Mitchell P, Wong TY. Are myopic eyes less likely to have diabetic retinopathy? Ophthalmology 2010;117(3):524-530.
  • 8Tewari HK, Gadia R, Kumar D, Venkatesh P, Garg SP.Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study.Invest Ophthalmol Vis Sci 2006;47(8):3474-3478.
  • 9Yannuzzi LA. Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 2010;149(3):361-363.
  • 10Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16(3):203-213.

同被引文献14

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部